NCM USA BRONX LLC FDA Approval ANDA 204515

ANDA 204515

NCM USA BRONX LLC

FDA Drug Application

Application #204515

Application Sponsors

ANDA 204515NCM USA BRONX LLC

Marketing Status

Prescription001

Application Products

001INJECTABLE;INTRAVENOUS3.75-260mCi/mL0AMMONIA N 13AMMONIA N-13

FDA Submissions

UNKNOWN; ORIG1AP2015-02-04

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAP

CDER Filings

Accessdata Error
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204515
            [companyName] => Accessdata Error
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.